Showing refined by:
-
AREXVY ▼ Respiratory syncytial virus (RSV) vaccine (recombinant, adjuvanted)
AREXVY patient information for members of the UK public -
Bexsero I GSK Public
Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet. -
Blenrep▼ (belantamab mafodotin)
Blenrep▼ (belantamab mafodotin) | Information for members of the public -
Boostrix-IPV
Information on Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) for members of public including summary of product characteristics and patient information leaflet -
Dectova ▼
Information on Dectova▼(zanamivir hydrate) for members of public including summary of product characteristics and patient information leaflet -
Flixotide (fluticasone propionate)
Flixotide (fluticasone propionate) support for members of the public. -
JEMPERLI ▼ (dostarlimab)
JEMPERLI▼ (dostarlimab) information for UK members of the public. -
MOP | SHINGRIX landing page
SHINGRIX patient information for members of the UK public -
Nucala (mepolizumab) overview for patients - GSK UK
Practical information for patients prescribed Nucala (mepolizumab) including understanding your diagnosis and how Nucala works. -
Priorix
Information on Priorix (Measles, Mumps and Rubella vaccine (live)) for members of public including summary of product characteristics and patient information leaflet -
Relenza
Information on Relenza (zanamivir) for members of public including summary of product characteristics and patient information leaflet -
Rotarix
Information on Rotarix (live attenuated rotavirus vaccine) for members of public including summary of product characteristics and patient information leaflet -
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public -
Ventolin (salbutamol)
Ventolin (salbutamol) support for members of the public. -
Zejula (niraparib)
Information for members of public on Zejula (niraparib)
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
There are no results matching your refine settings
Show more
Other products
Content is provided on this website for products with a United Kingdom product licence. In some cases, content may be provided relating to products that have mutual recognition or national licence, which has been created for United Kingdom audiences.
For safety and patient information relating to products not currently listed, please refer to the electronic Medicines Compendium website.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.
Additional note for medicines / vaccines with a black triangle:
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.
